These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21651515)

  • 1. ACVRL1 germinal mosaic with two mutant alleles in hereditary hemorrhagic telangiectasia associated with pulmonary arterial hypertension.
    Eyries M; Coulet F; Girerd B; Montani D; Humbert M; Lacombe P; Chinet T; Gouya L; Roume J; Axford MM; Pearson CE; Soubrier F
    Clin Genet; 2012 Aug; 82(2):173-9. PubMed ID: 21651515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia.
    Smoot LB; Obler D; McElhinney DB; Boardman K; Wu BL; Lip V; Mullen MP
    Arch Dis Child; 2009 Jul; 94(7):506-11. PubMed ID: 19357124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia.
    Rigelsky CM; Jennings C; Lehtonen R; Minai OA; Eng C; Aldred MA
    Am J Med Genet A; 2008 Oct; 146A(19):2551-6. PubMed ID: 18792970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
    Trembath RC; Thomson JR; Machado RD; Morgan NV; Atkinson C; Winship I; Simonneau G; Galie N; Loyd JE; Humbert M; Nichols WC; Morrell NW; Berg J; Manes A; McGaughran J; Pauciulo M; Wheeler L
    N Engl J Med; 2001 Aug; 345(5):325-34. PubMed ID: 11484689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.
    Girerd B; Montani D; Coulet F; Sztrymf B; Yaici A; Jaïs X; Tregouet D; Reis A; Drouin-Garraud V; Fraisse A; Sitbon O; O'Callaghan DS; Simonneau G; Soubrier F; Humbert M
    Am J Respir Crit Care Med; 2010 Apr; 181(8):851-61. PubMed ID: 20056902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
    Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
    BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mutations of ACVRL1 gene in a pedigree with hereditary hemorrhagic telangiectasia].
    Luo JW; Chen H; Yang LQ; Zhu AL; Wu YA; Li JW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):308-10. PubMed ID: 18543223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of clinically relevant mosaicism in type I hereditary haemorrhagic telangiectasia.
    Lee NP; Matevski D; Dumitru D; Piovesan B; Rushlow D; Gallie BL
    J Med Genet; 2011 May; 48(5):353-7. PubMed ID: 21415079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary hemorrhagic telangiectasia: evidence for regional founder effects of ACVRL1 mutations in French and Italian patients.
    Lesca G; Genin E; Blachier C; Olivieri C; Coulet F; Brunet G; Dupuis-Girod S; Buscarini E; Soubrier F; Calender A; Danesino C; Giraud S; Plauchu H;
    Eur J Hum Genet; 2008 Jun; 16(6):742-9. PubMed ID: 18285823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure and pulmonary arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia type 2.
    Du J; Zhu Y; Zhang YL; Li S; Huang J; Luo XH; Liu L
    J Thromb Thrombolysis; 2015 Nov; 40(4):515-9. PubMed ID: 26245826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mosaic ACVRL1 and ENG mutations in hereditary haemorrhagic telangiectasia patients.
    Best DH; Vaughn C; McDonald J; Damjanovich K; Runo JR; Chibuk JM; Bayrak-Toydemir P
    J Med Genet; 2011 May; 48(5):358-60. PubMed ID: 21378382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of multiple ACVRL1 mutations in patients with pulmonary arterial hypertension by targeted exome capture.
    Piao C; Zhu Y; Zhang C; Xi X; Liu X; Zheng S; Li X; Guo J; Jia L; Nakanishi T; Cai T; Gu H; Du J
    Clin Sci (Lond); 2016 Sep; 130(17):1559-69. PubMed ID: 27316748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary arterio-venous malformations in a patient with a novel mutation in exon 10 of the ACVRL1 gene.
    Vandenbriele C; Peerlinck K; de Ravel T; Verhamme P; Vanassche T
    Acta Clin Belg; 2014 Apr; 69(2):139-41. PubMed ID: 24724759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary hemorrhagic telangiectasia is caused by the Q490X mutation of the ACVRL1 gene in a large Arab family: support of homozygous lethality.
    El-Harith el-HA; Kühnau W; Schmidtke J; Gadzicki D; Ahmed M; Krawczak M; Stuhrmann M
    Eur J Med Genet; 2006; 49(4):323-30. PubMed ID: 16829353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary Hypertension and Hereditary Hemorrhagic Telangiectasia Related to an ACVRL1 Mutation.
    Yokokawa T; Sugimoto K; Kimishima Y; Misaka T; Yoshihisa A; Morisaki H; Yamada O; Nakazato K; Ishida T; Takeishi Y
    Intern Med; 2020 Jan; 59(2):221-227. PubMed ID: 31511490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ENG mutational mosaicism in a family with hereditary hemorrhagic telangiectasia.
    Tørring PM; Kjeldsen AD; Ousager LB; Brusgaard K
    Mol Genet Genomic Med; 2018 Jan; 6(1):121-125. PubMed ID: 29243366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical features and screening of ACVRL1 gene in II hereditary hemorrhagic telangiectasia].
    Jia JJ; Zhang J; Zhao LD; Zhou XJ; Cheng J; Yuan HJ; Wang HT
    Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(16):1107-11. PubMed ID: 22781769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients.
    Lesca G; Burnichon N; Raux G; Tosi M; Pinson S; Marion MJ; Babin E; Gilbert-Dussardier B; Rivière S; Goizet C; Faivre L; Plauchu H; Frébourg T; Calender A; Giraud S;
    Hum Mutat; 2006 Jun; 27(6):598. PubMed ID: 16705692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia associated with ACVRL1 mutation: a case report.
    Walsh LJ; Collins C; Ibrahim H; Kerins DM; Brady AP; O Connor TM
    J Med Case Rep; 2022 Mar; 16(1):99. PubMed ID: 35232468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and genetic analyses of three Korean families with hereditary hemorrhagic telangiectasia.
    Kim MJ; Kim ST; Lee HD; Lee KY; Seo J; Lee JB; Lee YJ; Oh SP
    BMC Med Genet; 2011 Oct; 12():130. PubMed ID: 21967607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.